Cryo-Cell International, Inc.
NASDAQ:CCEL
7.75 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 31.344 | 30.337 | 28.885 | 31.148 | 31.817 | 29.218 | 25.384 | 23.128 | 21.091 | 20.127 | 18.995 | 17.97 | 17.918 | 17.64 | 16.327 | 17.278 | 17.46 | 17.18 | 14.451 | 12.21 | 7.55 | 7.073 | 5.648 | 2.109 | 1.7 | 0.3 | 0.4 | 2.7 |
| Cost of Revenue
| 8.442 | 8.792 | 8.99 | 9.657 | 10.036 | 8.54 | 6.724 | 5.775 | 5.631 | 5.632 | 5.322 | 4.888 | 4.399 | 4.505 | 4.533 | 6.114 | 6.592 | 6.068 | 4.143 | 3.163 | 2.625 | 2.495 | 1.656 | 0.827 | 0.2 | 0.2 | 0 | 0.3 |
| Gross Profit
| 22.901 | 21.544 | 19.895 | 21.49 | 21.78 | 20.679 | 18.66 | 17.353 | 15.461 | 14.495 | 13.672 | 13.081 | 13.519 | 13.135 | 11.794 | 11.165 | 10.868 | 11.113 | 10.308 | 9.047 | 4.924 | 4.578 | 3.992 | 1.282 | 1.5 | 0.1 | 0.4 | 2.4 |
| Gross Profit Ratio
| 0.731 | 0.71 | 0.689 | 0.69 | 0.685 | 0.708 | 0.735 | 0.75 | 0.733 | 0.72 | 0.72 | 0.728 | 0.754 | 0.745 | 0.722 | 0.646 | 0.622 | 0.647 | 0.713 | 0.741 | 0.652 | 0.647 | 0.707 | 0.608 | 0.882 | 0.333 | 1 | 0.889 |
| Reseach & Development Expenses
| 1.171 | 0.385 | 0.05 | 0.024 | 0.03 | 0.092 | 0.041 | 0.053 | 0.046 | 0.064 | 0.036 | 0.11 | 0.184 | 0.133 | 0.102 | 0.194 | 0.545 | 0.486 | 0.026 | 0.083 | 0.227 | 0.22 | 0.051 | 0.276 | 0.1 | 0.4 | 0.2 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 15.633 | 13.481 | 14.723 | 12.389 | 12.252 | 11.366 | 14.426 | 12.413 | 9.485 | 8.937 | 10.827 | 14.463 | 12.957 | 9.104 | 6.274 | 9.712 | 6.056 | 3.951 | 2.854 | 2.3 | 1.9 | 1.8 | 1.5 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 17.116 | 15.58 | 14.625 | 14.294 | 14.891 | 15.633 | 13.481 | 14.723 | 12.389 | 12.252 | 11.366 | 14.426 | 12.413 | 9.485 | 8.937 | 10.827 | 14.463 | 12.957 | 9.104 | 6.274 | 9.712 | 6.056 | 3.951 | 2.854 | 2.3 | 1.9 | 1.8 | 1.5 |
| Other Expenses
| 16.918 | 1.12 | 0.835 | 0.166 | 0.206 | -0.025 | -0.08 | -0.015 | 0.023 | 0.21 | 0.049 | 0.204 | 0.571 | 0.294 | 1.083 | 0.409 | 0.532 | 0.629 | -0.046 | -0.489 | 2.508 | 3.84 | 0.476 | 0.313 | 0.1 | 0.2 | 0.1 | 0.1 |
| Operating Expenses
| 35.205 | 17.085 | 15.51 | 14.485 | 15.128 | 15.905 | 13.654 | 14.931 | 12.527 | 12.488 | 11.591 | 14.74 | 13.169 | 9.912 | 10.122 | 11.431 | 15.541 | 14.073 | 9.084 | 5.868 | 12.447 | 10.115 | 4.478 | 3.443 | 2.5 | 2.5 | 2.1 | 1.6 |
| Operating Income
| -12.304 | 4.024 | 4.003 | 7.662 | 5.063 | 5.189 | 5.006 | 0.434 | 2.933 | 1.981 | 1.703 | -1.711 | -0.277 | 3.222 | 1.672 | -0.327 | -4.673 | -2.96 | 1.224 | 3.18 | -7.523 | -5.537 | -0.486 | -2.161 | -1 | -2.4 | -1.7 | 0.8 |
| Operating Income Ratio
| -0.393 | 0.133 | 0.139 | 0.246 | 0.159 | 0.178 | 0.197 | 0.019 | 0.139 | 0.098 | 0.09 | -0.095 | -0.015 | 0.183 | 0.102 | -0.019 | -0.268 | -0.172 | 0.085 | 0.26 | -0.996 | -0.783 | -0.086 | -1.025 | -0.588 | -8 | -4.25 | 0.296 |
| Total Other Income Expenses Net
| -1.06 | -0.706 | -1.407 | -2.622 | -1.671 | -1.572 | -1.383 | -2.914 | -1.984 | -1.304 | -1.506 | -2.709 | -1.647 | -1.381 | -1.457 | -0.294 | -0.333 | 0.233 | -0.107 | -0.161 | -0.739 | -0.349 | 0.486 | 0.551 | 0.5 | 0 | 0.1 | -0.1 |
| Income Before Tax
| -13.364 | 3.319 | 2.611 | 5.039 | 3.391 | 3.618 | 3.624 | -2.48 | 0.95 | 0.677 | 0.197 | -4.42 | -1.697 | 1.781 | 1.547 | -0.76 | -5.005 | -2.727 | 1.117 | 3.019 | -7.521 | -5.166 | 0.776 | -1.61 | -0.5 | 0 | -1.6 | 0.7 |
| Income Before Tax Ratio
| -0.426 | 0.109 | 0.09 | 0.162 | 0.107 | 0.124 | 0.143 | -0.107 | 0.045 | 0.034 | 0.01 | -0.246 | -0.095 | 0.101 | 0.095 | -0.044 | -0.287 | -0.159 | 0.077 | 0.247 | -0.996 | -0.73 | 0.137 | -0.763 | -0.294 | 0 | -4 | 0.259 |
| Income Tax Expense
| -3.843 | 0.548 | 0.528 | 1.415 | 1.101 | 4.473 | 1.309 | -1.159 | -7.157 | 0.124 | 0.17 | 1.888 | 0.172 | -1.63 | 0.122 | 0.494 | 0.333 | -0.149 | -0.036 | 0.086 | 0.001 | 0.162 | -1.386 | -0.67 | -0.4 | -0.1 | -0.1 | 0.2 |
| Net Income
| -9.522 | 2.771 | 2.084 | 3.625 | 2.291 | -0.855 | 2.315 | -1.321 | 8.106 | 0.554 | 0.027 | -6.308 | -2.096 | 3.411 | 1.425 | -0.76 | -5.005 | -2.811 | 1.033 | 2.84 | -7.522 | -5.327 | 0.9 | -1.491 | -0.6 | -2.3 | -1.6 | 0.6 |
| Net Income Ratio
| -0.304 | 0.091 | 0.072 | 0.116 | 0.072 | -0.029 | 0.091 | -0.057 | 0.384 | 0.028 | 0.001 | -0.351 | -0.117 | 0.193 | 0.087 | -0.044 | -0.287 | -0.164 | 0.072 | 0.233 | -0.996 | -0.753 | 0.159 | -0.707 | -0.353 | -7.667 | -4 | 0.222 |
| EPS
| -1.14 | 0.33 | 0.26 | 0.48 | 0.29 | -0.11 | 0.33 | -0.16 | 0.85 | 0.05 | 0.003 | -0.56 | -0.18 | 0.29 | 0.12 | -0.065 | -0.43 | -0.24 | 0.09 | 0.25 | -0.66 | -0.47 | 0.09 | -0.15 | -0.073 | -0.32 | -0.23 | 0.09 |
| EPS Diluted
| -1.14 | 0.33 | 0.25 | 0.45 | 0.27 | -0.11 | 0.3 | -0.16 | 0.83 | 0.05 | 0.003 | -0.56 | -0.18 | 0.29 | 0.12 | -0.065 | -0.43 | -0.24 | 0.08 | 0.24 | -0.66 | -0.47 | 0.09 | -0.15 | -0.073 | -0.32 | -0.23 | 0.09 |
| EBITDA
| -10.417 | 6.65 | 5.317 | 7.219 | 5.496 | 5.482 | 5.156 | -1.246 | 2.495 | 2.206 | 1.992 | -1.346 | 0.113 | 3.645 | 3.634 | 1.379 | -3.931 | -2.236 | 1.821 | 3.837 | -6.329 | -5.161 | 0.027 | -1.848 | -0.9 | -2 | -1.4 | 0.9 |
| EBITDA Ratio
| -0.332 | 0.207 | 0.198 | 0.245 | 0.223 | 0.173 | 0.203 | 0.117 | 0.151 | 0.111 | 0.125 | -0.075 | 0.054 | 0.207 | 0.223 | 0.023 | -0.28 | -0.175 | 0.049 | 0.179 | -0.777 | -0.297 | -0.209 | -1.137 | -0.824 | -7.333 | -4.25 | 0.37 |